Angina pectoris, often shortened to angina, is chest pain or discomfort caused by reduced blood flow to the heart and most commonly—but not always—a symptom of coronary artery disease (CAD). The term ...

Add Yahoo as a preferred source to see more of our stories on Google. If angina pectoris – pain, pressure or tightness and shortness of breath – suddenly occurs even at rest, this can indicate an ...

In patients with angina but no obstructive arteries on angiography, further testing with stress cardiac MRI improved diagnosing the cause of angina, resulting in better management and quality of life, ...

Women with severe coronary heart disease causing narrowing or blockages in the arteries may derive greater long-term benefits from coronary artery bypass grafting compared with percutaneous coronary ...

Stress CMR significantly enhances diagnostic accuracy for chest pain without obstructive coronary artery disease, identifying microvascular angina often missed in standard angiography. The CorCMR ...

Please provide your email address to receive an email when new articles are posted on . In patients with heart attack without blocked arteries, a stratified treatment ...

An illustration of a magnifying glass. An illustration of a magnifying glass.

1 Department of Psychosomatic Dentistry, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan 2 Department of Cardiovascular Surgery, Graduate School of Medical and ...

Ask the publishers to restore access to 500,000+ books. An icon used to represent a menu that can be toggled by interacting with this icon. A line drawing of the Internet Archive headquarters building ...

Panelists discuss how the pathophysiology of acute myeloid leukemia has evolved from a single phenotype understanding to recognizing diverse genetic events that lead to transformation at the ...

WASHINGTON (AP) — A White House announcement about autism is expected Monday afternoon after President Donald Trump's weekend comment that "I think we found an answer" to the developmental disorder.

SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today ...